Physician profile
Miles E Saenger
NPI 1871149831
$5,417.34
in general payments reported to CMS, 2019-2025
40 companies · $856 in 2025
The $856 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,161 · 2022: $1,286 · 2023: $1,112 · 2024: $1,003 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,955 · Education: $15.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,954.85 |
| Education | $15.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $845.44 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $737.04 | 2021-2025 | |
| Pfizer INC. | $399.56 | 2021-2025 | |
| Glaxosmithkline, LLC. | $393.51 | 2021-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $269.07 | 2021-2025 | Airsupra, Farxiga |
| Amgen INC. | $260.40 | 2021-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $233.82 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.87 | 2021-2024 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $207.93 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Abbott Laboratories | $189.37 | 2021-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $138.98 | 2021-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $115.99 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $109.89 | 2022 | |
| Mylan Specialty L.P. | $95.50 | 2021-2023 | Yupelri |
| Sumitomo Pharma America, INC. | $95.31 | 2023-2025 | Gemtesa |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miles Saenger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.